bpc-157 and prostate cancer Everyone's talking about peptides like this… so let's actually look at the science. Yes — there is a study on cancer. But it's a 2004 conference abstract (not even a Drug triggers immune cells to

The modest savings aren't worth the significant risks

Research-Use Labelling and Canadian Compliance Requirements Canadian regulatory framing for injectable peptides has tightened throughout 2025 and 2026, and BPC-157 in particular has been named in multiple Health Canada advisories

Their conclusions mirror those of a white paper jointly published in May by the nonprofit ECRI and the Institute for Safe Medication Practices (ISMP)

If a compound has a 6-hour half-life, then six hours after peak concentration roughly 50% remains, at twelve hours 25%, at eighteen hours 12.5%

Recalls & Warnings January 16, 2014 Joint Health Supplement Contains Dangerous Drugs, FDA Warns On January 15, 2014, the FDA warned consumers not to buy or use joint health supplement Pro ArthMax (by Human Science Foundation) because it was found to contain multiple drugs, including diclofenac, ibuprofen, naproxen, indomethacin, nefopam, and chlorzoxazone